Navigation Links
EndyMed Announces the World's First 3DEEP RF Skin Tightening and Fractional Skin Resurfacing Combined Treatment Platform

CAESAREA, Israel, May 23, 2011 /PRNewswire/ -- EndyMed Medical, Ltd.,, a leader in the use of multi-source radiofrequency for professional aesthetic treatments, announced today that the results of a new study will be presented at the upcoming 22nd World Congress of Dermatology, in Seoul, Korea.  The study, which focused on combination therapy and was done with the EndyMed PRO system using proprietary 3DEEP RF technology, was conducted by Li-Lin Liu, M.D., of the Department of Dermatology in Taiwan.

(Photo: )

The EndyMed PRO treatment system is the world's first device that offers, on the same platform, both 3DEEP multi-source, phase controlled RF for face and body tightening plus the FDA cleared multisource fractional RF skin resurfacing.

The study centered on anti-aging treatment for dorsal hands and neck, body areas which are challenging to treat, which were treated using a combination of non-ablative 3DEEP RF technology and fractional 3DEEP RF technology to achieve effective and safe results.

Major conclusions of the study are:

  • For dorsal hands, 86% of the patients had improvement following six treatments and with one month follow-up.
  • The multi-source, phase controlled RF device was likely to improve the skin laxity and wrinkles on the dorsal hands and fingers.  
  • For the neck area, 71% of the patients had improvement following two treatments.
  • To treat deeper lines in the neck, it is expected that five to six sessions of the combination non-ablative and fractional 3DEEP RF treatments will prove effective on the bothersome and difficult to treat anti-aging complaint of deep neck lines.
  • Since collagen takes three to six months to regenerate, a six month follow-up will be amended to the study.
  • Patient satisfaction indicated high acceptance for 3DEEP RF Combination Therapy.
  • EndyMed PRO may become one of the most effective non-invasive therapies for wrinkle reduction, skin tightening and body contouring on the whole body.

  • EndyMed CEO, Uzi Blumensohn said, "We are pleased that Dr. Liu has studied the effects of the combination 3DEEP RF non-ablative and fractional technologies and is able to report at this important conference about his satisfied patients and effective results.  We are finding that physicians globally have begun to realize the benefits of 3DEEP RF Combination Therapy and we anticipate this will lead to increased demand among physicians worldwide for EndyMed PRO."

    According to Dr. Liu, "Patients today want answers for challenging skin conditions and previously, physicians would not have had good solutions for necks and hands. My patients are very pleased with their results from the 3DEEP Combination Therapy and I am very satisfied that I can offer a safe and effective solution."

    For more information, visit or contact us at the contact details below.

    About EndyMed Medical, Ltd.EndyMed Medical, Ltd. develops clinical solutions to rejuvenate aging and environmentally damaged skin. EndyMed is dedicated to providing the most effective products for the leading, global aesthetic treatments.  The company pioneered the development of multi-source radiofrequency technology, branded 3DEEP© RF, which is used in micro-ablative fractional and non-ablative aesthetic treatments. 3DEEP RF enables safe and effective results with minimal recovery time.  In February 2011, the EndyMed PRO Fractional Skin Resurfacing Applicator, which enables simultaneous epidermal fractional ablation and deep dermal volumetric heating, became the world's first multi-source, fractionally ablative radiofrequency device to be FDA cleared for skin resurfacing.

    EndyMed's management, clinical, marketing and R&D teams have extensive experience in the medical aesthetic market.  With proprietary 3DEEP radiofrequency technology and proprietary products like EndyMed PRO, the company is committed to changing the way aesthetic professionals perform fractional skin resurfacing, treat wrinkles, and provide skin tightening and body contouring solutions. 3DEEP technology is in products which are FDA cleared and CE marked.Contact:  

    Ann Berzak(e)  annb@endymed.comwww.endymed.comDistributor in USA:Eclipse Aesthetics, LLC.(t) 972 380 2911www.eclipseaesthetics.comEndyMed Medical™, EndyMed PRO™ 3DEEP® and 3DEEP Fractional Skin Resurfacing™ are trademarks or registered trademarks of EndyMed Medical, Ltd.

    SOURCE EndyMed Medical, Ltd.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. EndyMed Medicals Novel Multi-Source Radiofrequency Device Enables Real Time Skin Impedance Measurements
    2. Celladon Corporation Announces MYDICAR® Enzyme Replacement Therapy for Advanced Heart Failure Provides Sustained Reduction in Clinical Events in Patients for 18 Months Compared with Placebo
    3. Echo Therapeutics Announces Symphony™ tCGM System Progress
    4. Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations at the International Anesthesia Research Society 2011 Annual Meeting
    5. Amgen Announces Voting Results Of Annual Meeting of Stockholders
    6. Omron Healthcare Announces Donation to the American Society of Hypertension, Inc.
    7. Onyx Pharmaceuticals Announces Updated Pivotal Carfilzomib Phase 2B Data
    8. NxStage Announces Second Quarter 2011 Investor Conference Schedule
    9. Astellas Announces Vice President of Sales and Marketing for U.S. Oncology Franchise
    10. Families of Spinal Muscular Atrophy Announces Repligen Corporation Receives FDA Approval to Begin Phase I Clinical Trial in SMA
    11. Omeros Announces Clinical Development Programs for OMS103HP and OMS302
    Post Your Comments:
    (Date:11/27/2015)... UTRECHT , Niederlande, November 27, 2015 /PRNewswire/ ... mit fotodynamischer Bremachlorin-Therapie bei fortgeschrittenem Krebs.   ... fotodynamischer Bremachlorin-Therapie bei fortgeschrittenem Krebs.   --> ... fotodynamischer Bremachlorin-Therapie bei fortgeschrittenem Krebs.   ... berichtet. --> Clinical Cancer Research ...
    (Date:11/26/2015)... Países Bajos, November 26, 2015 ... fotodinámica de Bremachlorin para el cáncer avanzado.   ... con la terapia fotodinámica de Bremachlorin para el cáncer ... enfoque combina la inmunoterapia con la terapia fotodinámica de ... Clinical Cancer Research . --> Clinical Cancer ...
    (Date:11/26/2015)... -- Research and Markets ( ) has announced the ... to 2019 - Rise in Cardiac Disorders and Growing Awareness ... their offering. Boston scientific ... scientific and others. --> The market is ... Boston scientific and others. ...
    Breaking Medicine Technology:
    (Date:11/27/2015)... ... November 27, 2015 , ... The print ... USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation ... is distributed nationally, through a vast social media strategy and across a network ...
    (Date:11/27/2015)... ... November 27, 2015 , ... Consistent ... sharing, the 2016 Building Better Radiology Marketing Programs meeting will showcase ... Sunday, March 6, 2016, at Caesars Palace in Las Vegas with a pre-conference ...
    (Date:11/27/2015)... ... November 27, 2015 , ... The moment you stop improving ... only fulfilling the needs of advisers and clients but going above and beyond ... top-tier customer service. However, there's always room for improvement, which is why the ...
    (Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... the largest, most successful and prominent nonprofit healthcare organizations in the country. They ... involvement with various organizations, and helped advance the healthcare industry as a whole ...
    (Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
    Breaking Medicine News(10 mins):